InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,116.17
(
0.32%
)
US TECH 100
17,310.00
(
0.00%
)
Dow Jones
38,386.09
(
0.38%
)
Brent Oil
87.33
(
0.05%
)
Bitcoin
63,199.58
(
-1.00%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lasers

Send PM Follow Ignore
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

lasers

Re: lasers post# 71281

Thursday, 08/28/2014 7:40:50 PM

Thursday, August 28, 2014 7:40:50 PM

Post# of 92948
On the other hand if a Major Pharma were to make a bid for $ACTC would anything less than $1 bil be a fair value. IMO absolutely not.

Meanwhile Roche to Buy InterMune for $8.3 Billion

InterMune, based in Brisbane, Calif., has one product on the market: a drug called pirfenidone to treat idiopathic pulmonary fibrosis, a fatal scarring of the lungs. InterMune, which is still not profitable, sells pirfenidone under the name Esbriet in Europe and Canada, where it received regulatory approval in 2011 and 2012. The drug could receive approval in the United States by Nov. 23.



http://dealbook.nytimes.com/2014/08/24/roche-to-buy-drug-maker-intermune-for-8-3-billion/?_php=true&_type=blogs&_php=true&_type=blogs&_php=true&_type=blogs&_r=2

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up